methylprednisolone has been researched along with Bowel Diseases, Inflammatory in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.55) | 18.7374 |
1990's | 6 (27.27) | 18.2507 |
2000's | 5 (22.73) | 29.6817 |
2010's | 6 (27.27) | 24.3611 |
2020's | 4 (18.18) | 2.80 |
Authors | Studies |
---|---|
Ilyas, F | 1 |
Bai, F; Cao, Y; Che, D; Chen, H; Chen, P; Chen, Z; Cui, J; Delfouneso, D; Geng, L; Gong, S; Gu, X; Huang, B; Huang, W; Lew, AM; Li, D; Li, H; Liang, H; Liu, Y; Lu, B; Ren, L; Si, W; Su, M; Tang, WH; Wang, H; Wang, J; Wang, Y; Xian, H; Xie, J; Xu, B; Xu, Y; Yang, M; Ye, L; Zeng, L; Zhan, Y; Zhang, L; Zhang, T; Zhang, Y; Zhao, J; Zhao, S | 1 |
Bag-Ozbek, A; Elghawy, AA; Oh, KS; Pociurko, B; Skopis, M | 1 |
Boyars, M; George, B; Tanveer, N; Valaparla, V | 1 |
Avery, V; Chieng, M; Garg, P; Lane, M; Rowan, C; Schauer, C; Sekra, A; Seleq, S; Walmsley, R; Wang, MTM | 1 |
Abe, K; Arai, H; Isono, A; Nakamura, N; Saito, K; Toyota, H | 1 |
Bálint, A; Bor, R; Farkas, K; Molnár, T; Nagy, F; Szepes, Z; Szűcs, M; Valkusz, Z; Wittmann, T | 1 |
De Turck, BJ; Petrick, M; Vanbrabant, PR | 1 |
Bollen, L; Gils, A; Vermeire, S; Wuyts, J | 1 |
Berti, E; Cugno, M; Gelmetti, C; Marzano, AV; Tavecchio, S | 1 |
Han, P; Hodge, G; Hodge, S | 1 |
Donner, A; Neuhaus, H; Philipper, M; Schumacher, B | 1 |
Abu-Suboh Abadía, M; Casellas, F; Malagelada, JR; Vilaseca, J | 1 |
Bjursell, M; Bohlooly-Y, M; Gerdin, AK; Melgar, S; Michaëlsson, E; Svensson, L | 1 |
La Tulippe Naccarini, DA; Minor, ML | 1 |
Warren, BF; Watkins, PE | 1 |
Anić, B; Banić, M; Brkić, T; Duvnjak, M; Grabarević, Z; Mihatov, S; Rotkvić, I; Troskot, B | 1 |
Balasubramanian, S; Giannadaki, E; Greenstein, AJ; Manousos, ON; Mouzas, IA; Sachar, DB | 1 |
André, J; Cèzard, JP; Faure, C; Giraud, M; Jacqz-Aigrain, E; Munck, A; Pelatan, C | 1 |
Lemaire, M; Maldague, P; Noël, P | 1 |
Bensen, S | 1 |
Aiges, H; Daum, F; Kahn, E; Markowitz, J; Rosa, J; Simpser, E | 1 |
2 review(s) available for methylprednisolone and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Pyoderma gangrenosum associated with limited cutaneous systemic sclerosis: a rare case with literature review.
Topics: Arthritis, Rheumatoid; Humans; Inflammatory Bowel Diseases; Methylprednisolone; Pyoderma Gangrenosum; Scleroderma, Systemic | 2021 |
[Corticosteroid-induced epidural lipomatosis. Efficacy of medical treatment].
Topics: Adult; Anti-Inflammatory Agents; Cauda Equina; Epidural Space; Humans; Inflammatory Bowel Diseases; Lipomatosis; Magnetic Resonance Imaging; Male; Methylprednisolone; Nerve Compression Syndromes; Spinal Diseases; Treatment Outcome | 1998 |
2 trial(s) available for methylprednisolone and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Bolus administration of steroid therapy is more favorable than the conventional use in preventing decrease of bone density and the increase of body fat percentage in patients with inflammatory bowel disease.
Topics: Adipose Tissue; Adult; Body Mass Index; Bone Density; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Lipid Metabolism; Male; Methylprednisolone; Prospective Studies; Treatment Outcome | 2014 |
Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission.
Topics: Acute-Phase Reaction; Administration, Oral; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Methylprednisolone; Prednisone; Remission, Spontaneous; Treatment Outcome | 1998 |
18 other study(ies) available for methylprednisolone and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Successful low-dose corticosteroid treatment of aggressive pyoderma gangrenosum with irritable bowel syndrome: a case report.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Cellulitis; Female; Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Methylprednisolone; Middle Aged; Pyoderma Gangrenosum | 2022 |
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways.
Topics: Antigens, CD; Apyrase; B-Lymphocytes; Cell Death; Cellular Microenvironment; Child; Cohort Studies; Colon; Dendritic Cells; Dipyridamole; Endothelial Cells; Epithelial Cells; Fibroblasts; Gene Expression Regulation; Genetic Predisposition to Disease; Homeostasis; Humans; Immunoglobulin G; Immunologic Memory; Inflammation; Inflammatory Bowel Diseases; Interferon Type I; Intestinal Mucosa; Macrophages; Methylprednisolone; Myeloid Cells | 2019 |
A Case of Pyoderma Gangrenosum of Head and Neck Mimicking Purulent Cellulitis.
Topics: Adult; Anti-Inflammatory Agents; Cellulitis; Diagnosis, Differential; Gastrointestinal Agents; Head; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Methylprednisolone; Neck; Prednisone; Pyoderma Gangrenosum | 2021 |
A comparison of intravenous methylprednisolone and hydrocortisone for the treatment of acute inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Cohort Studies; Colitis; Colitis, Ulcerative; Humans; Hydrocortisone; Hypokalemia; Inflammatory Bowel Diseases; Methylprednisolone | 2021 |
Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents, Immunological; Biopsy; Colon; Colonoscopy; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lung Neoplasms; Methylprednisolone; Nivolumab | 2017 |
Sweet's or not: a cutaneous presentation of a severe disease.
Topics: Adult; Antineoplastic Agents; Blister; Clindamycin; Diagnosis, Differential; Humans; Inflammatory Bowel Diseases; Leukemia, Myeloid, Acute; Levofloxacin; Male; Methylprednisolone; Pyoderma Gangrenosum; Radiography; Skin; Sweet Syndrome | 2016 |
Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profile.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Female; Fibrin Clot Lysis Time; Humans; Inflammatory Bowel Diseases; Infliximab; Methylprednisolone; Risk Factors; Venous Thrombosis | 2016 |
Pustular Skin Reaction to Tumor Necrosis Factor Alpha Antagonists in Patients with Inflammatory Bowel Diseases.
Topics: Adalimumab; Adult; Antirheumatic Agents; Clobetasol; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Methylprednisolone; Skin; Skin Diseases; Tumor Necrosis Factor-alpha | 2015 |
Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Cell Survival; Cytokines; Flow Cytometry; Garlic; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Methylprednisolone; Monocytes; Plant Extracts; T-Lymphocytes | 2002 |
[Behçet's disease with gastrointestinal involvement without evidence for chronic inflammatory bowel disease].
Topics: Adult; Azathioprine; Behcet Syndrome; Chronic Disease; Diagnosis, Differential; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methylprednisolone; Treatment Outcome | 2004 |
Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy.
Topics: Adult; Female; Glucocorticoids; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Time Factors | 2004 |
Mice with experimental colitis show an altered metabolism with decreased metabolic rate.
Topics: Alanine Transaminase; Animals; Body Composition; Cholesterol; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Inflammatory Bowel Diseases; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Triglycerides | 2007 |
Cyclosporine and 6-mercaptopurine in pediatric inflammatory bowel disease.
Topics: Child; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methylprednisolone; Parenteral Nutrition, Total; Sulfasalazine | 1994 |
Effect of steroids in an IBD model.
Topics: Animals; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Methylprednisolone; Mice | 1993 |
Effect of methylprednisolone on small bowel, spleen and liver changes in a murine model of inflammatory bowel disease.
Topics: Animals; Disease Models, Animal; Ileum; Inflammatory Bowel Diseases; Leukocytes, Mononuclear; Liver; Lymphocyte Activation; Male; Methylprednisolone; Mice; Mice, Inbred BALB C; Spleen | 1993 |
Management of varicella infection during the course of inflammatory bowel disease.
Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Azathioprine; Cause of Death; Cephalexin; Cephalosporins; Chickenpox; Child; Colectomy; Colitis, Ulcerative; Crohn Disease; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Megacolon, Toxic; Methylprednisolone; Prednisone; Rectum; Remission Induction; Treatment Outcome | 1997 |
Heparin in the treatment of inflammatory bowel disease: dare we take the risk?
Topics: Anti-Inflammatory Agents; Anticoagulants; Colitis, Ulcerative; Glucocorticoids; Heparin; Humans; Inflammatory Bowel Diseases; Methylprednisolone; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2001 |
Does proctosigmoiditis in inflammatory bowel disease presage the imminent onset of symptoms?
Topics: Adolescent; Child; Child, Preschool; Colitis; Crohn Disease; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methylprednisolone; Proctocolitis; Prospective Studies; Sulfasalazine | 1989 |